Product Details

CISCRP looks inside patients’ perceptions, motives

The public’s views about the perceived safety of clinical trials and the motives of study volunteers have improved significantly during the past six years, and a large percentage of patients deemed ineligible to participate choose to take no action in finding another clinical trial. These are but a few of the findings of a new study of nearly 6,000 respondents worldwide conducted by the Center for Information & Study on Clinical Research Participation (CISCRP).

Strategies for finding, eliminating sites’ hidden costs

As a cottage industry, investigative sites continue to face mounting concerns about clinical trial costs which they either cannot collect or must negotiate with sponsors and CROs. These expenses can include everything from investigator meetings, IRB submissions, source documents, study preparation, site initiation and document storage, to the unexpected costs of paying staff when trials are delayed or postponed or having to wait 90 days or longer for payments from sponsors...

Also in this issue:

• Embracing reproducibility
• Small sponsors seek different strategic vendor fit
• Regulatory Update
• Month in Review
• FDA Actions
• Study Lead Opportunities
• New Drugs in the Pipeline